Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
NCT06058520Phase 1Recruiting
- Sponsor
- University of Minnesota
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Fecal Microbiota Transplantation Capsule in hidradenitis suppurativa (HS) (2 arms), sponsored by University of Minnesota. Primary endpoint: Percent donor engraftment at 12 weeks. Started Dec 2023; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT06058520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06058520.